TY - JOUR
T1 - Fraud in medical research
T2 - An international survey of biostatisticians
AU - Ranstam, Jonas
AU - Buyse, Marc
AU - George, Stephen L.
AU - Evans, Stephen
AU - Geller, Nancy L.
AU - Scherrer, Bruno
AU - Lesaffre, Emmanuel
AU - Murray, Gordon
AU - Edler, Lutz
AU - Hutton, Jane L.
AU - Colton, Theodore
AU - Lachenbruch, Peter
PY - 2000/10/1
Y1 - 2000/10/1
N2 - The characteristics of scientific fraud and its impact on medical research are in general not well known. However, the interest in the phenomenon has increased steadily during the last decade. Biostatisticians routinely work closely with physicians and scientists in many branches of medical research and have therefore unique insight into data. In addition, they have methodological competence to detect fraud and could be expected to have a professional interest in valid results. Biostatisticians therefore are likely to provide reliable information on the characteristics of fraud in medical research. The objective of this survey of biostatisticians, who were members of the International Society for Clinical Biostatistics, was to assess the characteristics of fraud in medical research. The survey was performed between April and July 1998. The participation rate was only 37%. We report the results because a majority (51%) of the participants knew about fraudulent projects, and many did not know whether the organization they work for has a formal system for handling suspected fraud or not. Different forms of fraud (e.g., fabrication and falsification of data, deceptive reporting of results, suppression of data, and deceptive design or analysis) had been observed in fairly similar numbers. We conclude that fraud is not a negligible phenomenon in medical research, and that increased awareness of the forms in which it is expressed seems appropriate. Further research, however, is needed to assess the prevalence of different types of fraud, as well as its impact on the validity of results published in the medical literature. Control Clin Trials 2000;21:415-427 Copyright (C) 2000 Elsevier Science Inc.
AB - The characteristics of scientific fraud and its impact on medical research are in general not well known. However, the interest in the phenomenon has increased steadily during the last decade. Biostatisticians routinely work closely with physicians and scientists in many branches of medical research and have therefore unique insight into data. In addition, they have methodological competence to detect fraud and could be expected to have a professional interest in valid results. Biostatisticians therefore are likely to provide reliable information on the characteristics of fraud in medical research. The objective of this survey of biostatisticians, who were members of the International Society for Clinical Biostatistics, was to assess the characteristics of fraud in medical research. The survey was performed between April and July 1998. The participation rate was only 37%. We report the results because a majority (51%) of the participants knew about fraudulent projects, and many did not know whether the organization they work for has a formal system for handling suspected fraud or not. Different forms of fraud (e.g., fabrication and falsification of data, deceptive reporting of results, suppression of data, and deceptive design or analysis) had been observed in fairly similar numbers. We conclude that fraud is not a negligible phenomenon in medical research, and that increased awareness of the forms in which it is expressed seems appropriate. Further research, however, is needed to assess the prevalence of different types of fraud, as well as its impact on the validity of results published in the medical literature. Control Clin Trials 2000;21:415-427 Copyright (C) 2000 Elsevier Science Inc.
UR - http://www.scopus.com/inward/record.url?scp=0033833235&partnerID=8YFLogxK
U2 - 10.1016/S0197-2456(00)00069-6
DO - 10.1016/S0197-2456(00)00069-6
M3 - Article
C2 - 11018560
AN - SCOPUS:0033833235
SN - 0197-2456
VL - 21
SP - 415
EP - 427
JO - Controlled Clinical Trials
JF - Controlled Clinical Trials
IS - 5
ER -